List of Tables
    Table 1. Disease Control and Prevention Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Disease Control and Prevention Vaccine Market Trends
    Table 3. Disease Control and Prevention Vaccine Market Drivers
    Table 4. Disease Control and Prevention Vaccine Market Challenges
    Table 5. Disease Control and Prevention Vaccine Market Restraints
    Table 6. Global Disease Control and Prevention Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Disease Control and Prevention Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Disease Control and Prevention Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Disease Control and Prevention Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Disease Control and Prevention Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Disease Control and Prevention Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Disease Control and Prevention Vaccine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Disease Control and Prevention Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Disease Control and Prevention Vaccine Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Disease Control and Prevention Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2021)
    Table 18. Top Players of Disease Control and Prevention Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Disease Control and Prevention Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Disease Control and Prevention Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Disease Control and Prevention Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Disease Control and Prevention Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Disease Control and Prevention Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Disease Control and Prevention Vaccine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Disease Control and Prevention Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Disease Control and Prevention Vaccine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Disease Control and Prevention Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Disease Control and Prevention Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Disease Control and Prevention Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Disease Control and Prevention Vaccine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Disease Control and Prevention Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. GSK Corporation Information
    Table 43. GSK Description and Business Overview
    Table 44. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. GSK Disease Control and Prevention Vaccine Product
    Table 46. GSK Recent Development
    Table 47. Merck & Co., Inc Corporation Information
    Table 48. Merck & Co., Inc Description and Business Overview
    Table 49. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Merck & Co., Inc Product
    Table 51. Merck & Co., Inc Recent Development
    Table 52. Pfizer Corporation Information
    Table 53. Pfizer Description and Business Overview
    Table 54. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Pfizer Product
    Table 56. Pfizer Recent Development
    Table 57. Sanofi Corporation Information
    Table 58. Sanofi Description and Business Overview
    Table 59. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Sanofi Product
    Table 61. Sanofi Recent Development
    Table 62. AstraZeneca PLC Corporation Information
    Table 63. AstraZeneca PLC Description and Business Overview
    Table 64. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. AstraZeneca PLC Product
    Table 66. AstraZeneca PLC Recent Development
    Table 67. Sinovac Biotech Ltd Corporation Information
    Table 68. Sinovac Biotech Ltd Description and Business Overview
    Table 69. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Sinovac Biotech Ltd Product
    Table 71. Sinovac Biotech Ltd Recent Development
    Table 72. Astellas Pharma Inc Corporation Information
    Table 73. Astellas Pharma Inc Description and Business Overview
    Table 74. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Astellas Pharma Inc Product
    Table 76. Astellas Pharma Inc Recent Development
    Table 77. Serum Institute of India Pvt. Ltd Corporation Information
    Table 78. Serum Institute of India Pvt. Ltd Description and Business Overview
    Table 79. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Serum Institute of India Pvt. Ltd Product
    Table 81. Serum Institute of India Pvt. Ltd Recent Development
    Table 82. Daiichi Sankyo Corporation Information
    Table 83. Daiichi Sankyo Description and Business Overview
    Table 84. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Daiichi Sankyo Product
    Table 86. Daiichi Sankyo Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Disease Control and Prevention Vaccine Customers List
    Table 90. Disease Control and Prevention Vaccine Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Disease Control and Prevention Vaccine Product Picture
    Figure 2. Global Disease Control and Prevention Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Disease Control and Prevention Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Disease Control and Prevention Vaccine Sales 2017-2028 (K Units)
    Figure 5. United States Disease Control and Prevention Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Disease Control and Prevention Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Disease Control and Prevention Vaccine Sales 2017-2028 (K Units)
    Figure 8. United States Disease Control and Prevention Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Disease Control and Prevention Vaccine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Disease Control and Prevention Vaccine Report Years Considered
    Figure 11. Product Picture of Live-Attenuated
    Figure 12. Product Picture of Inactivated
    Figure 13. Product Picture of Recombinant Sub Unit and Toxoid
    Figure 14. Global Disease Control and Prevention Vaccine Market Share by Type in 2022 & 2028
    Figure 15. Global Disease Control and Prevention Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Disease Control and Prevention Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Disease Control and Prevention Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Disease Control and Prevention Vaccine Market Share by Type in 2022 & 2028
    Figure 21. United States Disease Control and Prevention Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Disease Control and Prevention Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Disease Control and Prevention Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Disease Control and Prevention Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Disease Control and Prevention Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Pediatric Vaccine
    Figure 27. Product Picture of Adult Vaccine
    Figure 28. Global Disease Control and Prevention Vaccine Market Share by Application in 2022 & 2028
    Figure 29. Global Disease Control and Prevention Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Disease Control and Prevention Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Disease Control and Prevention Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Disease Control and Prevention Vaccine Market Share by Application in 2022 & 2028
    Figure 35. United States Disease Control and Prevention Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Disease Control and Prevention Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Disease Control and Prevention Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Disease Control and Prevention Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Disease Control and Prevention Vaccine Value Chain
    Figure 74. Disease Control and Prevention Vaccine Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed